USAID’s “IMPACTblog”: How Progress Works: A Disappointing Microbicides Trial and Why We’re Not Discouraged
David Stanton, director of USAID’s Office of HIV/AIDS, discusses “results released from a large USAID-supported trial [which] indicate that an antiretroviral-based vaginal gel may not be effective in reducing the risk of HIV infection in women when used before and after sex.” He says, “Although the answer wasn’t what we’d hoped, in the process of asking we have learned and grown, and we’ll redouble our efforts to take the next steps forward…” (2/24).